Leverage Innovation for Technology Transfer Fund (LSU LIFT2) Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2016
NCT02740660
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

albuterol (proventil) (1 trial)

caffeine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2